Literature DB >> 7125738

The early diagnosis of gastrinoma.

I M Modlin, B M Jaffe, A Sank, D Albert.   

Abstract

Despite the increasing awareness of gastrinoma and its lethal peptic ulcer sequelae, the diagnosis is often initially missed or made as a terminal event. The authors screened all patients with peptic ulcer symptoms serious enough to warrant hospital admission or those associated with diarrhea, nephrolithiasis, hypercalcemia, or pituitary abnormality. In a one-year period (1979-1980) nine (of 14 suspected) new gastrinoma patients were identified using a sensitive and specific gastrin radioimmunoassay in combination with provocative tests including IV secretin, calcium, and food. Conventional upper GI series, CAT scan, arteriography, and endoscopy provided no additional information other than to confirm the presence of ulcer disease. Basal plasma gastrin levels were more than 200 pmol L-1 in only three of the nine (normal fasting plasma gastrin levels are less than 25 pmol L-1). Three patients presented with acute ulcer perforation, and the diagnosis of gastrinoma was suspected because of multiple ulcers and pancreatic masses. In three other patients, previous duodenal ulcer surgery had failed. One patient with dyspepsia, high basal plasma gastrin, negative secretin and calcium infusion studies, and a positive meal test was diagnosed as having G-cell hyperplasia; this was confirmed by biopsy and antral gastrin extraction. Antrectomy alone resulted in cure. In all patients tested, a positive calcium infusion or secretin bolus (greater than 100% rise over basal) strongly suggested the diagnosis of gastrinoma, which was confirmed at surgery. In the acute perforations, initial management with omental patch and cimetidine therapy allowed survival of two patients, while emergency total gastrectomy in the third resulted in death due to esophagojejunal leak. Elective patients were treated with cimetidine initially for at least two weeks before total gastrectomy. In this group there were no operative mortalities, and postoperative morbidity was minimal. This series illustrates three important points: (1) careful screening of an ulcer population using gastrin radioimmunoassay and provocative tests has enabled a high yield of gastrinomas while conventional investigations are of minimal values; (2) a high index of suspicion in appropriate cases is necessary; and (3) total gastrectomy performed under elective circumstances is safe and allows the patients to resume a normal and healthy life without the sequelae of aggressive peptic ulceration or daily drug administration.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7125738      PMCID: PMC1352781          DOI: 10.1097/00000658-198211000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

1.  Pancreatic vein catheterization with gastrin assay in normal patients and in patients with the Zollinger-Ellison syndrome.

Authors:  S Ingemansson; L I Larsson; A Lunderquist; F Stadil
Journal:  Am J Surg       Date:  1977-11       Impact factor: 2.565

2.  Use of calcium and secretin in the diagnosis of gastrinoma (Zollinger-Ellison syndrome).

Authors:  C W Deveney; K S Deveney; B M Jaffe; R S Jones; L W Way
Journal:  Ann Intern Med       Date:  1977-12       Impact factor: 25.391

Review 3.  Surgical management of the Zollinger-Ellison syndrome.

Authors:  P S Fox; J W Hofmann; S D Wilson; J J DeCosse
Journal:  Surg Clin North Am       Date:  1974-04       Impact factor: 2.741

4.  Antral-gastrin-cell hyperplasia in peptic-ulcer disease.

Authors:  P C Ganguli; J M Polak; A G Pearse; J B Elder; M Hegarty
Journal:  Lancet       Date:  1974-04-06       Impact factor: 79.321

5.  Effect of total gastrectomy on the Zollinger-Ellison tumor: observations by second-look procedures.

Authors:  S R Friesen
Journal:  Surgery       Date:  1967-10       Impact factor: 3.982

6.  Unusual effect of secretin on serum gastrin, serum calcium, and gastric acid secretion in a patient with suspected Zollinger-Ellison syndrome.

Authors:  J I Isenberg; J H Walsh; E Passaro; E W Moore; M I Grossman
Journal:  Gastroenterology       Date:  1972-04       Impact factor: 22.682

7.  Comparative study of the value of the calcium, secretin, and meal stimulated increase in serum gastrin to the diagnosis of the Zollinger-Ellison syndrome.

Authors:  C G Lamers; J H Van Tongeren
Journal:  Gut       Date:  1977-02       Impact factor: 23.059

8.  The influence of total gastrectomy on survival in malignant Zollinger-Ellison tumors.

Authors:  P S Fox; J W Hofmann; J J Decosse; S D Wilson
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

9.  Nutritional consequences of total gastrectomy.

Authors:  E L Bradley; J Isaacs; T Hersh; E D Davidson; W Millikan
Journal:  Ann Surg       Date:  1975-10       Impact factor: 12.969

10.  The Zollinger-Ellison syndrome--23 years later.

Authors:  C W Deveney; K S Deveney; L W Way
Journal:  Ann Surg       Date:  1978-09       Impact factor: 12.969

View more
  5 in total

Review 1.  Calcium sensing by endocrine cells.

Authors:  Edward M Brown
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

2.  The role of surgery in the Zollinger-Ellison syndrome.

Authors:  J C Thompson; B G Lewis; I Wiener; C M Townsend
Journal:  Ann Surg       Date:  1983-05       Impact factor: 12.969

3.  Resection of gastrinomas.

Authors:  C W Deveney; K E Deveney; D Stark; A Moss; S Stein; L W Way
Journal:  Ann Surg       Date:  1983-10       Impact factor: 12.969

Review 4.  Current diagnosis and management of Zollinger-Ellison syndrome.

Authors:  D K Andersen
Journal:  Ann Surg       Date:  1989-12       Impact factor: 12.969

5.  Effects of intravenous calcium on release of serotonin into jejunal lumen and portal circulation.

Authors:  S R Money; K Kimura; A Petroianu; B M Jaffe
Journal:  Dig Dis Sci       Date:  1988-08       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.